| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6121533 | Journal of Clinical Virology | 2012 | 6 Pages |
Abstract
Reactivation rate of resolved hepatitis B is not negligible in patients without anti-HBs antibodies at transplantation. We suggest monitoring of liver tests and HBV serology including HBsAg and anti-HBs antibodies after transplantation as well as vaccination pre- and post-transplantation in all patients, including those with resolved hepatitis B, aiming at maintaining anti-HBs antibody level above 100Â IU/L.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Nada Kanaan, Benoit Kabamba, Céline Maréchal, Yves Pirson, Claire Beguin, Eric Goffin, Ziad Hassoun,